CanBas Co., Ltd.
4575・Growth Market・Pharmaceuticals
Governance
The company has a Board with an Audit and Supervisory Committee. The Board of Directors consists of 6 members: 3 full-time directors and 3 outside directors who are members of the Audit and Supervisory Committee (outside director ratio: 50%). All 3 members of the Audit and Supervisory Committee are independent outside directors, and all directors achieved a 100% attendance rate at Board meetings (16 meetings held during the fiscal year). No nomination committee or compensation committee has been confirmed to exist.
Risk Management
The company has established crisis management regulations, under which, in the event of a significant risk occurring, an emergency response headquarters headed by the President is immediately set up and an extraordinary board of directors meeting is convened. Key risks identified by each responsible director are shared with the Board of Directors and, where necessary, reflected in the business plan with input from outside experts. A compliance support system is also in place through advisory agreements with law firms.
Shareholder Returns
No dividends since founding. Zero annual dividend of ¥0.00 also forecast for FY2026 (ending June 2026). As the company is in a stage of front-loaded R&D investment, it does not plan to pay dividends for the time being. No share buybacks have been confirmed.
Dividend Policy
The annual dividend is ¥0.00 (both the FY2025 (ended June 2025) actual and the FY2026 (ending June 2026) forecast are ¥0.00). The company currently has no products on the market and is in a stage of front-loaded investment, advancing research and development of candidate compounds including CBP501; therefore, it does not pay dividends. Since its founding, the company has not paid any profit dividends or distributions of surplus to shareholders. Going forward, for the time being, the company intends to prioritize allocating funds toward strengthening its corporate structure and R&D activities, and will not pay dividends.
ESG
The company's basic sustainability policy comprises three pillars: (1) environmental contribution and workplace environment improvement through DX promotion, (2) creating a workplace where diverse professional talent can thrive, and (3) strengthening corporate governance. Internally, the company has implemented a flextime system, a paid leave utilization rate of approximately 80%, a 100% return-to-work rate after maternity leave, and encouragement of male employees to take childcare leave (recent uptake rate of 100%). The proportion of women in managerial positions is 33.3%, and the gender wage gap (all workers) is 69.2%. The company is considering establishing a Sustainability Promotion Committee (tentative name). As the organization has only 14 employees, quantitative monitoring indicators have not yet been established.
Last updated: September 29, 2025